Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Perdana Bangun Pusaka Tbk (KONI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Perdana Bangun Pusaka TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Perdana Bangun Pusaka Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Perdana Bangun Pusaka Tbk trades at Rp2,680 (market cap 867.36B, 59.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Perdana Bangun Pusaka Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 59.1K). Which is the better fit depends on your goals.

KONILABS
Market Cap
867.36B576.7B
Volume
59.1K3.48M
Lot
59134.82K
Turnover
159.3M522.79M
Average Price
2,695.43150.13
Value
159.3M522.79M
Indicative Equilibrium Price
2,680148
Indicative Equilibrium Volume
7350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KONI
View details
LABS
View details

About Perdana Bangun Pusaka Tbk

PT. Perdana Bangun Persaka Tbk conducting business in the field of photography trade business and its equipment, and capital participation in its affiliates. The company is established in 1987 and registered at the Jakarta Stock Exchange since 1995 and a sole distributor of photography products produced by Konica Corporation, Japan. Product marketed by the company are as follows: KONICA color film and photography paper, KONICA photo printing machine, KONIKA X-ray film and chemicals for photography of KONICA trade mark.

Read more on KONI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS